Capillary Technologies hosts analyst meet at Emkay Confluence 2026
Capillary Technologies India Limited announced a physical group meeting with analysts and institutional investors scheduled for August 12, 2026, during Emkay Confluence 2026. Filed under Regulation 30 of the SEBI Listing Regulations, the disclosure confirms that no unpublished price-sensitive information will be shared. The company secretary certified the notice, which was submitted to both BSE and NSE on August 03, 2026.

*this image is generated using AI for illustrative purposes only.
Capillary Technologies will host a group meeting with analysts and institutional investors on August 12, 2026, as part of the Emkay Confluence 2026 conference. The physical event provides market participants with an opportunity to engage with company management regarding business operations and strategy. This interaction is scheduled under the regulatory framework governing investor disclosures, ensuring transparency while maintaining strict compliance with information dissemination rules. The meeting underscores the company’s commitment to regular engagement with its financial stakeholders.
The intimation was filed with the Bombay Stock Exchange and the National Stock Exchange of India Limited on August 03, 2026, pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms the schedule and nature of the upcoming interaction.
Meeting Details
The specific parameters of the analyst meet are outlined below:
| Date | Event Name | Meeting Type | Mode |
|---|---|---|---|
| August 12, 2026 | Emkay Confluence 2026 | Group Meeting | Physical |
The company noted that the schedule may be subject to change due to exigencies involving participants or the company itself. Investors are advised to monitor official communications for any updates regarding timing or venue adjustments.
Regulatory Compliance and Information Policy
A critical component of the disclosure is the assurance that no Unpublished Price Sensitive Information (UPSI) will be discussed during the interaction. This restriction aligns with SEBI’s guidelines to prevent insider trading and ensure equitable access to material information among all investors. By explicitly stating this boundary, Capillary Technologies reinforces its adherence to fair disclosure practices.
The announcement was signed by Gireddy Bhargavi Reddy, Company Secretary and Compliance Officer, from Bengaluru. The full text of the intimation has been placed on the company’s website under the corporate announcements section for public record. This procedural step ensures that all shareholders and interested parties have immediate access to the details of the scheduled engagement.
Historical Stock Returns for Capillary Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.36% | +4.05% | -3.48% | -17.60% | -18.29% | -18.29% |
What specific strategic initiatives or growth metrics is Capillary Technologies likely to highlight during the Emkay Confluence 2026 session?
How might the insights shared by management influence institutional investor sentiment and short-term stock volatility following the August 12 meeting?
Are there any anticipated regulatory changes in India's retail tech sector that Capillary Technologies may address as part of its compliance and strategy discussion?


































